Hanmi challenges against Pfizer

Published: 2012-10-22 07:00:00

Updated: 2012-10-22 07:00:00

Pfizer Korea filed a suit against Hanmi Pharmaceutical Co. at the Seoul Central District Court for patent infringement, claiming the latter’s Palpal tablet infringed Vigra’s tablet design.

In response to the lawsuit, Hanmi side said Thursday that its design is different from that of Viagra, in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK